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Abstract 
NETosis is a host defense mechanism associated with inflammation and tissue 
damage. Experimental models show that platelets and von Willebrand factor (VWF) are 
key elements for intravascular NETosis.  
We determined NETosis in septic and burn patients at 1 and 4 days post-admission 
(dpa). 
Nucleosomes were elevated in patients. In septics, they correlated with Human 
Neutrophil Elastase (HNE)-DNA complexes and SOFA score at 1dpa, and were 
associated with mortality. 
Patient’s neutrophils had spontaneous NETosis and were unresponsive to stimulation. 
Although platelet P-selectin and TNF- were increased in both groups, higher platelet 
TLR4 expression, VWF levels and IL-6 were found in septics at 1 dpa. Neither platelet 
activation markers nor cytokines correlated with nucleosomes or HNE-DNA.  
Nucleosomes could be indicators of organ damage and predictors of mortality in septic 
but not in burn patients. Platelet activation, VWF and cytokines do not appear to be key 
mediators of NETosis in these patient groups. 
 
Keywords: Neutrophils, NETs, Sepsis, Inflammation, Platelets, Burn 
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Abbreviations 
cfDNA: cell free DNA; Cit: citrullinated; dpa: days post admission; HNE: human 
neutrophil elastase; ICU: intensive care unit; LPS: lipopolysaccharide; NET: neutrophil 
extracellular trap; PRP: platelet rich plasma; PI: propidium iodide; PGI2: prostacyclin; 
SIRS: systemic inflammatory response syndrome; TBSA: total body surface area; TNF-
tumor necrosis factor alpha; WP: washed platelets; VWF: von Willebrand factor. 
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1. Introduction 
The formation of neutrophil extracellular traps (NETs) is a novel antimicrobial process 
named NETosis through which neutrophils can trap and kill microbes [1]. Despite 
NETosis being initially described as a beneficial host response against pathogens, it is 
being increasingly recognised that the uncontrolled formation of these traps switches 
NETosis from a beneficial response into a major cause of tissue damage and organ 
failure [2-4]. Besides pathogens, cytokines or danger signals can trigger NET formation 
[5]. Thus, NETs can be formed not only in infectious conditions but also under 
inflammatory sterile states. In addition, NETs can be found in tissues as well as inside 
blood vessels [6]. Experimental models show that platelets, von Willebrand factor 
(VWF) and endothelial cells are key elements for the intravascular formation of NETs 
[7-9]. The role of these factors in NETosis occurring under clinical conditions is yet to 
be investigated. 
Sepsis and severe burns are two acute inflammatory conditions, one triggered by an 
infectious insult and the other by tissue injury. Even though they share many aspects, 
and multiorgan failure is frequent in both pathologies, the evolution of these two entities 
is not exactly the same. Although early mortality in burn patients is mostly due to 
hypovolemic shock and inhalation injuries, in septic patients, multiorgan damage is the 
most frequent cause of death, being respiratory and renal failure the most common 
among them [10]. Following the initial 5–7 days period, the evolution of the burn patient 
becomes similar to that of the septic, existing three possible states, early death 
associated to a highly pro-inflammatory profile, resolution of the infection and 
progressive improvement of the organ function due to an adequate balance between 
pro- and anti-inflammatory states, or torpid and lengthy evolution due to a tendency to 
immunosuppression from the onset of the disease. It is noteworthy that multiorgan 
failure prevalence is higher in burn patients when they present acute inhalation injury in 
a similar way to what happens during sepsis-associated respiratory distress [11]. In this 
context, several studies in animal models have proven that the lung would be a key 
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organ in the NET formation process [6, 12, 13] and that it is there where a critical 
interaction between platelets and neutrophils takes place, leading to a systemic release 
of NETs and inflammatory cytokines. 
Despite multiple technological breakthroughs in the support and treatment of the 
etiology, septic and burn patient’s morbi-mortality remains high. Clinical management 
of these patients is challenging and largely limited to supportive therapies, which is in 
part related to a limited understanding of the underlying pathophysiology. After the 
discovery of the NETosis process, some studies in septic and a few in burn patients 
have analysed the role of cell free DNA (cfDNA) or nucleosomes in these inflammatory 
diseases. However, these biomarkers can be released upon several conditions 
including necrosis, apoptosis or NETosis, [14] and therefore, the real involvement of 
NETs in clinical inflammatory conditions is still not clear. In order to further understand 
the role of NETs in the inflammatory response, herein we aimed to determine the 
presence of NETs in septic and burn patients and correlate them with organ damage, 
patient evolution, platelet activation, VWF and pro-inflammatory cytokines. 
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2. Materials and Methods 
2.1. Ethics statement 
This study was conducted according to the principles expressed in the Declaration of 
Helsinki and was approved by the Ethical Committee of the National Academy of 
Medicine, Bazterrica Clinic and Burns Hospital, Buenos Aires, Argentina. All individuals 
provided written informed consent for the collection of samples and subsequent 
analysis. 
2.2. Subjects 
The study was designed as a prospective cohort study. Inclusion criteria:  
The subjects were patients admitted to the intensive care unit (ICU) of Bazterrica Clinic 
and Burns Hospital from April 2015 to December 2016. The study population consisted 
of 24 septic and 23 burned patients and 30 healthy adult volunteers who were not 
receiving any medication at the time of blood sampling. No attempt to match cases and 
controls was made.  
Severe sepsis was diagnosed if all criteria of systemic inflammatory response 
syndrome (SIRS), evidence of two or more organ dysfunctions, and a proven septic 
focus were present, according to the ACCP/SCCM consensus conference [15]. 
Diagnosis of SIRS required at least two of the following: temperature <36°C or >38°C, 
heart rate >90/min, respiration rate >20/min or arterial PCO2 <32mmHg and white 
blood cell (WBC) count >12,000/mm3 or <4000/mm3, or shift to the left of the 
differential WBC count with band forms 10%. To evaluate organ dysfunction and the 
severity of illness, the SOFA score was determined. 
Burn patients were included when presented with a burn degree of III and IV in the 
Garces index and samples were collected within 24 hs of the traumatic event. Burn 
total body surface area (TBSA) percent was determined at admission.  
Patients were excluded from this study when anticoagulated for pre-existing 
pathologies, previous thrombotic events, previous platelet dysfunction or deep vein 
thrombosis history. We excluded patients less than 18 years of age, pregnant, with 
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chronic renal failure, and if within 14 days of a surgical procedure. Clinical data related 
to the course of hospitalization, including need for invasive mechanical ventilation, 
occurrence of system organ failure and clinical outcomes were recorded. 
 
2.3. Reagents 
RPMI 1640 medium and Ficoll–Hypaque (1.077 g/m density) were purchased from GE 
Healthcare (Buckinghamshire, UK). Dextran from Leuconostoc spp, purified LPS 
derived from Escherichia coli O111:B4, poly-L-Lysine, thymus DNA and propidium 
iodide (PI) were purchased from Sigma Aldrich (St. Louis, MO, USA). SYBR gold and 
anti-rabbit Alexa 488 were purchased from Invitrogen (Carlsbad, CA, USA) 
Prostacyclin (PGI2) was purchased from Cayman, (Ann Arbor, MI, USA). 
Recombinant TNF-α was from Peprotech (Rocky Hill, NJ, USA). Micrococcal nuclease 
(MNase), cell death detection ELISAPLUS kit andperoxidase-labeled anti-DNA mAb 
were purchased from Roche Diagnostics (Mannheim, Germany). Rabbit anti-human 
neutrophil elastase (HNE) antibody was from Calbiochem-Merck Millipore (Darmstadt, 
Germany). Human interleukin (IL)-6 and human TNF-α ELISA kits were purchased 
from eBioscience (San Diego, CA, USA). FITC-conjugated mouse anti-human CD62P 
and FITC-conjugated irrelevant IgG1 were from Becton Dickinson (San Jose, CA, 
USA). Anti-human VWF and HRP-conjugated anti-human VWF were obtained from 
Dako (Glostrup, Denmark). PE-conjugated anti-human TLR-4 and PE-conjugated 
irrelevant IgG2a were from BioLegend (San Diego, CA, USA). 
  
2.4. Blood sampling and testing 
Collection of blood samples from septic patients was performed within 24 hs from 
admission to the ICU and 4 days later. Venous blood was collected aseptically from 
each patient and donor into EDTA–coated pyrogen-free tubes. The WBC count and the 
neutrophil count were determined with an automated analyser (Diatron, Hungary). 
Blood samples were processed within 2 hs of collection. 
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2.5. Isolation of neutrophils 
Neutrophils were isolated by Ficoll Hypaque gradient centrifugation and dextran 
sedimentation, as described previously [16]. Cell suspensions contained >98% 
neutrophils, as determined with an automated analyser. Cells were resuspended in 
RPMI 1640 supplemented with fetal bovine serum (FBS, 1%). 
 
2.6. Preparation of platelets 
Platelet rich plasma (PRP) from normal donors and patients was obtained by the 
centrifugation of blood samples (180 × g for 10 min). For washed platelet (WP) 
suspensions, PRP was centrifuged in the presence of 75 nM PGI2. After washing in 
wash buffer, the WP were resuspended in RPMI 1640 supplemented with FBS (1%) at 
2.4 × 108/ml. Platelets were incubated with 1g/ml LPS for 30 min at 37°C [16]. 
  
2.7. Ex vivo NET formation 
Neutrophils (5 × 105/ml) were incubated alone, with platelets, LPS and LPS-stimulated 
platelets or 20 ng/ml of TNF- for 1 and 3 hs, respectively, in a humidified incubator at 
37°C with CO2 (5%). In all experiments, NET formation was visualised by 
immunofluorescence microscopy and quantified by evaluation of the released DNA in 
the supernatants by fluorometry [16].  
 
2.8. Immunofluorescence assays 
Neutrophils were adhered on poly-L-lysine-treated coverslips and placed in 24-well, 
flat-bottom plates. After stimulation, the cells were fixed with paraformaldehyde (PFA 
1%) and blocked with 5% heat inactivated FBS. Cells were then stained with rabbit 
anti-HNE (1:1000) or the corresponding IgG controls and the secondary antibody anti-
rabbit Alexa 488. DNA was stained with PI (2 mg/ml) and the coverslips were mounted 
on slides. Mounted specimens were analysed by confocal fluorescence microscopy 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
using a FV-1000 microscope (Olympus, Tokyo, Japan) equipped with a Plapon 
360/NA1.42 objective [16].  
 
2.9. Quantification of extracellular DNA 
DNA released from neutrophils during NETosis was digested with MNase (500 mU/ml) 
for 15 min. EDTA (5 mM) was added to stop the nuclease activity. Supernatants were 
collected, centrifuged, and DNA was measured in the supernatants using SYBR Gold 
in a fluorometer (BioTek Instruments, VT, USA). The calibration curve was constructed 
using thymus DNA of a known concentration [17]. 
  
2.10. Measurement of nucleosomes, VWF, IL-6 and TNF-α 
Plasma from healthy donors and patients was obtained by blood centrifugation (900 × 
g for 10 min). Plasmatic levels of nucleosomes, IL-6 and TNF- were measured using 
commercial ELISA kits. Plasmatic levels of VWF were determined by ELISA as 
described previously using human VWF antibody and HRP-conjugated human VWF 
antibody as primary and secondary antibodies, respectively. The results were 
expressed in ng/ml and extrapolated from serial dilutions of normal pooled plasma, 
assuming a 7 μg/ml VWF concentration [16]. 
 
2.11. HNE–DNA complexes ELISA 
Quantification of HNE-DNA complexes was performed as previously described [13]. 
Briefly, 96-well plates were coated with 5 mg/ml anti-HNE antibody overnight at 4°C. 
After washing three times, plasma samples were added with incubation buffer 
containing a peroxidase-labeled anti-DNA mAb (dilution 1:25). The plate was then 
incubated for 2 h, shaking at 300 rpm at room temperature (RT). After three washes, 
100 ml of peroxidase substrate (ABTS) were added. Absorbance at 405 nm 
wavelength was measured after 20 min incubation at RT in the dark. Values for soluble 
HNE-DNA complexes were expressed as optical density (OD). 
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2.12. Flow cytometry 
Aliquots of PRP were fixed and stained with a FITC-CD62P (anti-P-selectin) or an 
equivalent amount of isotype-matched control Ab. For detection of TLR-4, aliquots of 
PRP were stained with PE-conjugated anti-TLR4 or PE-conjugated irrelevant IgG2a as 
isotype control. 
Staining was performed by 30 minutes incubation in the dark at RT. Then, samples 
were fixed with PFA (1%) and analysed by flow cytometry on a FACSCalibur using 
CELLQUEST software (Becton Dickinson, San Jose, CA, USA) and results were 
expressed as mean of fluorescence intensity (MFI). 
  
2.13. Statistical analysis 
Data were analysed for normality using the Shapiro-Wilk test. Univariate analysis for 
both patient groups was conducted using median and 25–75 interquartile range (IQR). 
Differences between quantitative data (patients vs. healthy donors) were explored 
using median nonparametric tests. A Spearman correlation was used to compare 
nonparametric variables (septic patients SOFA score, burn patients TBSA percent, 
nucleosome levels and HNE-DNA complexes) and the corresponding R square 
coefficients were obtained. 
Patient’s initial response (1 dpa) was compared between patients groups and with 
healthy donors using Kruskal-Wallis test. In order to assess patients’ evolution, the 
inflammatory response after 4 dpa was compared intra and inter groups. 
Logistic regression was conducted to examine the relationships between nucleosome 
levels and mortality within 30 days from admission to the ICU. Infostat and GraphPad 
softwares were used for the statistical analyses. Values of p < 0.05 (two tailed) were 
considered statistically significant. 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
3. Results 
3.1. Patients 
Demographic and clinical data for the 47 enrolled patients are shown in Table 1. The 
age difference between septic and burn patients is due to the epidemiology of both 
pathologies, where at both global and regional level, the average age for sepsis is 69 
years old [18] while for burn patients it is 40 years old mostly due to work -related 
accidents [19].  
Even though thrombocytopenia (platelet count <140 × 109/l) was observed in 21% of 
septic patients and 39% of burn patients, overall, no statistical differences with healthy 
donors were found. 
 
Table 1. 
Patient’s demographics at admission to the ICU. 
Variable Sepsis Burns 
N 24 23 
Age in years (IQR) 70 (64:79) 39 (26:45) 
Female sex 11 8 
SOFA score (sepsis) 7 (5:10) - 
TBSA % (burn) - 33 (25:39) 
Survived > 31 days (Y:N) 19:5 17:6 
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Days in ICU (IQR) 20 (9:36) 42 (28:45) 
MOF (Y:N) 24:0   
WBC 109/l (IQR) 17 (11:22) 10 (6:12) 
Lymphocytes 109/l (IQR) 0.75 (0.6:1.4) 1.1 (0.7:1.4) 
Granulocytes 109/l (IQR) 15 (10:20) 9 (4:11) 
Platelets 109/l (IQR) 223 (151:305) 186 (125:280) 
Plasma VWF (IQR) 33 (25:44) 25 (20:29) 
Plasma TNF-  (IQR) 120 (0:292) 90 (25:139) 
Plasma IL-6 (IQR) 351 (64:428) 63 (19:156) 
Y:N = Yes/No; MOF = multiple organ failure. 
 
3.2. Nucleosomes and HNE-DNA complex are increased in septic and burn 
patients 
To explore the occurrence of NETosis in septic and burn patients, levels of circulating 
nucleosomes were analysed at 1 and 4 dpa to the ICU. Figure 1 A shows that both 
groups of patients had significantly increased nucleosomes levels at 1 dpa compared 
to control subjects and remained elevated by 4 dpa. 
Since nucleosomes can be released not only during NETosis, but also as a result of 
other cellular processes like necrosis or apoptosis [14], we also analysed the presence 
of HNE-DNA complexes that are specific indicators of NET formation [13]. Figure 1 B 
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depicts the levels of HNE-DNA complexes determined by ELISA. Similar to 
nucleosomes, while healthy donors had almost no circulating levels of HNE-DNA 
complexes, septic and burn patients showed significantly higher levels than controls 
throughout the study. 
Remarkably, while nucleosomes showed good correlation with the HNE-DNA 
complexes in septic patients either at 1 or 4 dpa, there was no correlation of these two 
parameters in burn patients at any time studied (Fig. 1 C). Studying patients severity, 
we found that nucleosomes levels correlated with septic’s SOFA score at 1dpa (p = 
0.03) explaining near 20% of SOFA’s variability (R2 = 0.195, Fig. 1 D). No significant 
correlations were found between nucleosome levels and TBSA% in burn patients (Fig. 
1 E).  
In septic patients, nucleosome levels at admission were associated with mortality 
(Wald = 5.31, p = 0.02). This was not the case with burn patients (Wald = 0.14, p = 
0.71).  
 
3.3. Patient’s neutrophils spontaneously form NETs and are unresponsive to 
stimuli 
Besides pathogens, NETs can be triggered by several stimuli including cytokines [20] 
and activated platelets [13, 16, 21]. To determine the ability of patient’s neutrophils to 
generate NETs, we examined NETosis induced by LPS in the absence or presence of 
platelets and by the pro-inflammatory TNF-. As expected, immunofluorescence 
studies showed that non-stimulated neutrophils from healthy donors in the absence or 
presence of platelets did not undergo NETosis (Fig. 2 A). Although addition of LPS or 
TNF- (Fig. 2 A) significantly induced NETs, pre-stimulation of platelets with LPS 
increased NETosis. In contrast, neutrophils from septic or burn patients formed NETs 
spontaneously and they did not respond to further stimulation with LPS-activated 
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platelets or TNF- (Fig. 2 A). Similar results were obtained when DNA release was 
quantified by fluorometry (Fig. 2 B). 
 
3.4 Platelet Activation, VWF levels and NETs formation 
In experimental mice models of sepsis, platelets and VWF appeared to be required for 
intravascular NET formation [7-9]. To analyse whether a similar situation occurs under 
inflammatory clinical conditions we evaluated platelet count, expression of P-selectin 
and circulating VWF levels in septic and burn patients. 
Even though it has been reported that sepsis and burns often leads to 
thrombocytopenia [22], we encountered a great variability in the platelet count in both 
groups of patients resulting in no statistical differences between them and healthy 
donors (Fig. 3 A). However, flow cytometry studies revealed that platelets from septic 
and burn patients showed an augmented expression of P-selectin (Fig. 3 B). 
Considering that platelet TLR4 is a critical mediator of NET formation [6], we also 
analysed this receptor’s expression. Septic patients showed an increased expression 
of TLR4 compared to healthy donors at 1 dpa and remained elevated at 4 dpa. In 
contrast, in burn patients, the TLR4 increased was only observed after 4 dpa (Fig. 3 C). 
As expected, ELISA quantitation showed significantly higher values of VWF in septic 
and burn patients compared to control samples. However, in burn patients, the levels of 
VWF were higher at 4 dpa than at 1 dpa. (Fig. 3 D) 
Despite evidence of platelet activation and increased levels of VWF in septic and burn 
patients, linear regression analysis showed no correlation between these biomarkers 
and nucleosomes or HNE-DNA complexes. 
 
3.5 Inflammatory cytokines are not associated with NETs formation neither in 
septic nor in burn patients 
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Considering the involvement of the pro-inflammatory cytokines IL-6 and TNF- in the 
acute phase response of sepsis and severe burns [23, 24] and their role as triggers of 
NETosis [5, 20], we studied their levels in the plasma of septic and burn patients. 
Although IL-6 and TNF- were not detectable in the plasma of healthy donors, septic 
and burn patients had very high levels of both cytokines at 1 dpa. IL-6 was higher in 
septics compared to burn patients at admission and in the former, these values were 
significantly reduced at 4 dpa but still remained higher than the control group (Fig. 4). 
On the other hand, TNF- levels showed no variation after 4 dpa in either group. 
None of these cytokines showed any association with levels of nucleosomes or HNE-
DNA complexes nor did they seem to play a role in organ damage scores or mortality. 
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4. Discussion 
In this study, we have shown that nucleosomes and HNE-DNA complexes are elevated 
in both septic and burn patients, but only in septic patients, nucleosomes correlated 
with organ damage and were predictors of mortality. Despite platelet activation and 
increased levels of inflammatory cytokines, neither of them appeared to be triggers of 
DNA release on the population studied. 
Increased levels of cfDNA leading to high discriminative power to predict ICU mortality 
in patients with severe sepsis have been previously reported [25-27]. However, since 
cfDNA can be released not only during NETosis, but through various cellular processes 
including necrosis or apoptosis [14], the real role of NETs could not be extrapolated 
from these studies. The positive correlation between nucleosomes and HNE-DNA 
complexes observed in septic patients in our study indicates that nucleosomes most 
probably reflect NETs formation. On the other hand, the direct relationship between 
levels of nucleosomes, but not of HNE-DNA complexes with SOFA score, together with 
the fact that nucleosomes are good predictors of mortality, suggests that extracellular 
DNA is, among other factors, involved in the organ damage of septic patients and a 
more sensitive biomarker than HNE-DNA complexes. Moreover, we found that 
neutrophils from septic patients had a higher level of spontaneous NETosis and they 
were not capable of responding to further stimuli compared to control neutrophils. 
Several factors have been reported to be involved in the induction of NETs. Therefore, 
it is possible that exposure of leukocytes to high levels of endogenous and exogenous 
mediators released during sepsis could have rendered these cells unresponsive to 
stimuli. In fact, plasma levels of inflammatory cytokines known to prime and activate 
neutrophils such as IL-6 and TNF- were elevated in the population of septic patients 
studied. Our data are in agreement with the study of Masamitsu Hashiba et al [27] who 
found not only an impaired NET formation in response to PMA stimulation but also an 
ineffective E. coli killing by NETs formed by neutrophils purified from septic patients. 
The inability of neutrophils from septic patients to form NETs upon stimulation might 
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represent another mechanism by which neutrophil dysfunction promotes sepsis and 
even leads to organ failure [28]. 
In experimental mice models, it has been shown that platelets, endothelium and VWF 
are intimately involved in the formation of intravascular NETs [7-9]. Our observation 
that platelets from septic patients had increased expression of P-selectin and TLR4 
indicated an ongoing process of platelet activation. In addition, we also found increased 
levels of VWF in these patients. However, neither of these biomarkers correlated with 
HNE-DNA complexes nor nucleosomes suggesting that at least in this studied 
population and contrary to animal models, platelets and VWF do not appear to take 
part in the development of NETs. TLRs are well known receptors involved in 
recognising pathogens and initiating innate immune responses [29]. Even though 
platelets express all members of the TLR family [30, 31], their role in the 
physiopathology of the inflammatory response is still not clear. It was suggested that 
platelet TLR4 functions as a barometer for systemic infection, binding avidly to 
sequestered neutrophils during septicemia and endotoxemia in the capillaries of lungs 
and liver leading to the rapid formation of NETs, which maintain their integrity under 
flow conditions [6]. Thus, even though we could not find a positive correlation with 
NETs, we do not discard the possibility that the increased expression of platelet TLR4 
observed in our study was associated with an augmented recruitment and adhesion of 
neutrophils. 
Similar to septic patients, NETosis is not yet clearly identified in burn patients. Three 
studies showed that cfDNA levels are significantly increased already on day 1 after 
admission [32] and two others that cfDNA is a valuable marker for prediction of 
mortality [33, 34]. However, the source of this DNA and whether it reflected the 
formation of NETs was not addressed in either of the studies. In contrast, in a recent 
study, it was observed that cfDNA was elevated only after 7 days in burn patients 
during septic episodes. Interestingly, they also found the presence of plasmatic 
citrullinated (Cit)-H3, a direct indicator of NET formation, in nine patients. However, as 
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there were no quantitative data of Cit-H3 levels, correlation between these two 
biomarkers was not established [35]. In our study, we found increased levels of 
nucleosomes and HNE-DNA complexes at admission to the ICU and 4 days after. In 
contrast to septic patients, there was not a positive correlation between these two 
biomarkers indicating that the origin of nucleosomes include other sources of cellular 
death beyond NETosis and highlighting that measurement of cfDNA cannot be 
considered an index of NET formation in these patients. Moreover, neither 
nucleosomes nor HNE-DNA complexes correlated with the burn surface area 
suggesting that they are not directly involved in nor are a consequence of tissue 
damage. Like septics, burn patients showed an increase ex vivo basal formation of 
NETs and the neutrophils were unresponsive to further stimulation. These data are in 
agreement with those obtained by Hampson et al who also found reduced NETosis by 
PMA stimulation in burn-injured patients at days 3 and 7 post injury. In addition, burn 
patients had increased P-selectin expression as well as high levels of VWF and pro-
inflammatory cytokines at day 1 post admission compared to healthy controls. 
However, the degree of the inflammatory response in burns was milder than in septic 
patients as they showed no increase in platelet TLR4 expression and the levels of VWF 
and IL-6, despite being higher than healthy controls, were significantly lower in burn 
than in septic patients. Notably, at 4 day after admission, platelet TLR4 expression 
increased together with plasmatic level of VWF. Even though it could be reasoned that 
the increase of these biomarkers was associated to a septic episode, none of the 
patients studied showed clinical signs of sepsis or had positive bacteria cultures. 
In conclusion, our results indicate that regardless whether the inflammatory insult is 
infectious or not, nucleosomes and HNA-DNA complexes are augmented in vivo and 
ex vivo in septic and burn patients. Although nucleosomes appear to be involved in the 
tissue damage of sepsis and are potential predictors of mortality, they do not have the 
same relevance in burn patients. 
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Despite progress being made in improving treatment for sepsis and severe burns, they 
both are pathologies with high mortality rates. The relevance that nucleosomes seem 
to have in the evolution of sepsis, points towards nucleosomes quantification being a 
feasible new biomarker which could be used alongside well-established ICU severity 
scores in order to improve outcome prediction in patients and provide new tools for 
physicians in their effort to advance on benchside care.  
Larger studies with a longer follow-up are needed in order to better assess the 
sensitivity and specificity of NETs as potential predictors of death in septic patients. 
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Figure captions 
Fig. 1. Circulating nucleosomes and NETs.  
A) Nucleosome levels and B) HNE-DNA complex levels (OD) were measured in 
plasma by ELISA in septic (n = 24) and burned (n = 23) patients compared with 
controls (n = 30). **p < 0.01, ****, p < 0.001, Kruskal–Wallis. Correlation between 
nucleosome levels and HNE–DNAcomplexes for C) septics and B) burned patients at 1 
and 4 dpa, Spearman test. Correlation between nucleosome levels and D) SOFA 
Score for septics or  E) Total Body Surface Area percentage (TBSA %) for burned 
patients at 1 and 4 dpa, Spearman test. 
Fig. 2. Ex vivo NETs formation.  
A) Neutrophils (5 × 105/ml) were placed on poly-L-lysine-treated coverslips in 24-well, 
flat-bottom plates and incubated alone, with LPS, platelets (Plts), and LPS-stimulated 
platelets or 20ng/ml of TNF-α for 1 and 3 hs, respectively, in a humidified incubator at 
37°C with CO2 (5%). Cells were then fixed and stained for PI (red) and HNE (green). B) 
DNA release was quantified in the supernatants by fluorometry. Results were 
compared vs non-stimulated healthy donors and between groups, *p < 0.05, Kruskal–
Wallis. 
Fig. 3. Platelets and endothelium activation. 
A) Platelet count was obtained using an automated analyser and expressed as cells 
per liter. B) Platelet P-selectin and C) TLR4 expression were measured by flow 
cytometry and expressed as MFI, *p < 0.05, **p < 0.01, Kruskal–Wallis. D) VWF 
plasmatic levels were measured by ELISA and are expressed as µg/ml, *p < 0.05, ***p 
< 0.001, Kruskal–Wallis. 
Fig. 4. Plasma levels of IL-6 and TNF-α in septic and burn patients. 
Plasma A) IL-6 and B) TNF-α were quantified by ELISA and results are expressed as 
pg/ml. *p < 0.05, ***p < 0.001, Kruskal–Wallis. 
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Highlights 
 Nucleosomes and HNE-DNA complexes are elevated in septic and burn 
patients. 
 Septics’ nucleosomes correlate with SOFA at 1dpa and were associated with 
mortality. 
 Patient’s neutrophils exhibit spontaneous NETosis and are unresponsive to 
stimulation. 
 Nucleosomes could be organ damage indicators and mortality predictors in 
septics. 
 Platelets, VWF and cytokines do not seem to mediate NETosis in these 
patients. 
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